Psychiatry and Neurology, Neurology · Annapolis, MD
NPI
1699063925
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2002 Medical Pkwy, Suite 430
Annapolis, MD, 21401
Phone (443) 481-1940
Groups this clinician bills Medicare through
Medicare paid, 2024
$118K
1,043 services
Medicare patients, 2024
551
Average age 75
Drug cost, 2024
$866K
1,499 prescriptions
Company payments, 2025
$2,187
From 26 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shariff S Dunlap was code 99214 (office e&m - established), 270 times for 209 patients. In total Shariff S Dunlap billed 1,043 services in 20 codes, and Medicare paid $118K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 270 | 209 | $92.00 | $25K |
| 99205 Office E&M - New | Office | 197 | 197 | $171.24 | $34K |
| 99215 Office E&M - Established | Office | 193 | 168 | $143.88 | $28K |
| 99213 Office E&M - Established | Office | 172 | 152 | $64.67 | $11K |
| 95886 Electrical Nerve Conductivity | Office | 91 | 52 | $76.97 | $7,004 |
| 95910 Electrical Nerve Conductivity | Office | 27 | 27 | $126.41 | $3,413 |
| 99204 Office E&M - New | Office | 14 | 14 | $85.34 | $1,195 |
| 95913 Electrical Nerve Conductivity | Office | 12 | 11 | $219.20 | $2,630 |
By year: 2022 $115K for 992 services; 2023 $104K for 928 services; 2024 $118K for 1,043 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shariff S Dunlap prescribed most often to Medicare patients was Donepezil Hcl, with 216 prescriptions and refills. In total Shariff S Dunlap wrote 1,499 Medicare prescriptions that cost $866K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 216 | 500 | 82 | $2,539 |
| Memantine Hcl Generic | 146 | 312 | 47 | $7,351 |
| Levetiracetam Generic | 89 | 200 | 25 | $4,898 |
| Gabapentin Generic | 73 | 172 | 26 | $1,698 |
| Pregabalin Generic | 72 | 82 | 16 | $2,104 |
| Lacosamide Generic | 63 | 71 | 13 | $7,409 |
| Topiramate Generic | 51 | 133 | 19 | $651 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 45 | 120 | 19 | $1,003 |
| Duloxetine Hcl Generic | 37 | 83 | Under 11 | $694 |
| Primidone Generic | 34 | 98 | 13 | $963 |
| Clonazepam Generic | 31 | 31 | Under 11 | $364 |
| Lamotrigine Generic | 30 | 84 | Under 11 | $426 |
| Quetiapine Fumarate Generic | 29 | 74 | Under 11 | $555 |
| Amitriptyline Hcl Generic | 28 | 56 | Under 11 | $549 |
| Rizatriptan Rizatriptan Benzoate | 28 | 28 | 12 | $760 |
Brand drugs: 182 claims; generic drugs: 1,317 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shariff S Dunlap $2,187 ($2,187 in general payments such as food, travel and fees) from 26 companies. The largest payer was Abbvie Inc. with $339.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 16 | $339 |
| Teva Pharmaceuticals USA, Inc. TEVA | 14 | $268 |
| Novartis Pharmaceuticals Corporation NVS | 15 | $261 |
| Pfizer Inc. PFE | 9 | $180 |
| Celgene Corporation BMY | 5 | $110 |
| Lundbeck LLC | 4 | $94.55 |
| Biogen, Inc. BIIB | 4 | $92.62 |
| Amgen Inc. AMGN | 4 | $83.76 |
| Grifols USA, LLC | 3 | $83.08 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $80.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.